Regulatory Effects of Curcumin on Platelets: An Update and Future Directions.
Yaseen HussainAbdullah KhanFazlullah KhanKhalaf F AlsharifKhalid J AlzahraniSarmistha SahaHaroon KhanPublished in: Biomedicines (2022)
The rhizomatous plant turmeric, which is frequently used as a spice and coloring ingredient, yields curcumin, a bioactive compound. Curcumin inhibits platelet activation and aggregation and improves platelet count. Platelets dysfunction results in several disorders, including inflammation, atherothrombosis, and thromboembolism. Several studies have proved the beneficial role of curcumin on platelets and hence proved it is an important candidate for the treatment of the aforementioned diseases. Moreover, curcumin is also frequently employed as an anti-inflammatory agent in conventional medicine. In arthritic patients, it has been shown to reduce the generation of pro-inflammatory eicosanoids and to reduce edema, morning stiffness, and other symptoms. Curcumin taken orally also reduced rats' acute inflammation brought on by carrageenan. Curcumin has also been proven to prevent atherosclerosis and platelet aggregation, as well as to reduce angiogenesis in adipose tissue. In the cerebral microcirculation, curcumin significantly lowered platelet and leukocyte adhesion. It largely modulated the endothelium to reduce platelet adhesion. Additionally, P-selectin expression and mice survival after cecal ligation and puncture were improved by curcumin, which also altered platelet and leukocyte adhesion and blood-brain barrier dysfunction. Through regulating many processes involved in platelet aggregation, curcuminoids collectively demonstrated detectable antiplatelet activity. Curcuminoids may therefore be able to prevent disorders linked to platelet activation as possible therapeutic agents. This review article proposes to highlight and discuss the regulatory effects of curcumin on platelets.
Keyphrases
- blood brain barrier
- oxidative stress
- adipose tissue
- newly diagnosed
- transcription factor
- cardiovascular disease
- subarachnoid hemorrhage
- nitric oxide
- pseudomonas aeruginosa
- endothelial cells
- high fat diet
- long non coding rna
- ultrasound guided
- extracorporeal membrane oxygenation
- cystic fibrosis
- prognostic factors
- respiratory failure
- case control